Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; D
-
Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Dilut
-
Bombardier Completes Partial Redemption of US$200,000,000 of its 7.875% Senior Notes due 2027
-
SmartFinancial Announces Results for the First Quarter 2024
-
Parker to Announce Fiscal 2024 Third Quarter Earnings on May 2; Conference Call and Webcast Scheduled for 11 a.m. Eastern Time
-
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
-
Finning to report Q1 2024 results on May 6 and hold investor call on May 7, 2024
-
NCLA Amicus Brief Tells D.C. Circuit It Must Avoid Remanding Regulations Without Vacating Them
-
Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
-
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
-
EMGA secures US$ 15M financing for Banco Improsa in Costa Rica
-
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27t
-
Ring Therapeutics Announces Presentations at the 27th Annual American Society of Gene and Cell Therapy
-
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
-
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
-
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
-
iLearningEngines Reports Fourth Quarter and Full Year 2023 Results
-
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
-
Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
-
Tessera Therapeutics to Present New Data Across Preclinical Programs for its Gene Writing™ and Delivery Platforms at the American Society of Gene and Cell Therapy 27th Annual Meeting
-
BIO-key International, Inc. Receives Notice of Non-Compliance from Nasdaq
-
GeneFab Announces Two Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
-
Kriya Announces Six Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2024
-
Excision BioTherapeutics Announces Oral Presentation Highlighting Positive Data from its HBV Program, EBT-107, at the Upcoming ASGCT 2024 Annual Meeting
-
CNL FINANCIAL GROUP ANNOUNCES NEW NATIONAL SALES DIRECTOR
-
Fate Therapeutics Announces Presentation of FT819 Proof-of-Concept Data for B cell-mediated Autoimmune Diseases at ASGCT Annual Meeting
-
Cellectis Presents Novel TALEN® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
-
CrossAmerica Partners LP Maintains Quarterly Distribution
-
CrossAmerica Partners LP Maintains Quarterly Distribution
-
Vertex Provides Preliminary Financial Results for First Quarter 2024 and Announces First Quarter Earnings Call Date
-
Vertex, Inc. Announces Proposed Private Offering of $250 Million of Convertible Senior Notes
-
NBT Bancorp Inc. Announces First Quarter 2024 Results
-
PetIQ, Inc. to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
-
TopBuild Announces Mutual Termination of Agreement to Acquire Specialty Products and Insulation
-
Oportun Announces Preliminary Q1 2024 Financial Information
-
Howard Community College, Community Action Council Finalize Partnership to Reopen Campus Childcare Center
-
Critical Metals Appoints Tony Sage as Chief Executive Officer
-
Profound Medical to Release First Quarter 2024 Financial Results on May 9 – Conference Call to Follow
-
Atico Produces 3.34 Million Pounds of Cu and 2,156 Ounces of Au in First Quarter 2024
-
Archrock Announces Timing for First Quarter 2024 Results
-
Capital Bancorp, Inc. Reports First Quarter 2024 Results
-
Pyrophyte Acquisition Corp. Receives NYSE Notice Regarding Delayed Form 10-K Filing
-
The RealReal Launches Retail Initiative to Benefit Conservation International
-
Biden-Harris Administration Announces Major Steps to Stand Up Landmark American Climate Corps Initiative, Mobilizing the Next Generation of Climate Leaders
-
Triumph Financial to Live Stream Annual Meeting
-
Calavo Growers, Inc. to Provide General Business Update at 2024 Annual Meeting of Shareholders
-
Fluence Energy, Inc. Announces Second Quarter 2024 Earnings Release Date, Conference Call and Webcast
-
Saga Communications, Inc. Announces Date and Time of 1st Quarter 2024 Earnings Release and Conference Call
-
Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer
-
El Pollo Loco Holdings, Inc. to Announce First Quarter 2024 Results on Thursday, May 2, 2024

